Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

A WHO-backed study reveals that overweight postmenopausal women with heart disease face a 31 per cent higher breast cancer ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Obesity in itself is not a contraindication to radical prostatectomy, but it remains a risk factor for poor overall survival. Although obesity increases the technical complexity of radical ...

Obesity and heart failure often go together, making treatment more complicated. Now, health experts have released new ...

Zuellig Pharma, a leading healthcare solutions provider in Asia, is organizing the "Obesity is a Disease" seminar as part of ...

Understanding the link between obesity, fatty liver disease and kidney stones provides a new perspective on prevention and ...

The number of overweight and obese adults in India is expected to rise from 180 million in 2021 to an 449 million by 2050.

When a team of scientists led by a Washington State University researcher examined the way that more than 9,400 children grew ...

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.